0001209191-23-043441.txt : 20230726 0001209191-23-043441.hdr.sgml : 20230726 20230726170555 ACCESSION NUMBER: 0001209191-23-043441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230724 FILED AS OF DATE: 20230726 DATE AS OF CHANGE: 20230726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirk Christopher J. CENTRAL INDEX KEY: 0001744253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38542 FILM NUMBER: 231114345 MAIL ADDRESS: STREET 1: C/O KEZAR LIFE SCIENCES, INC. STREET 2: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kezar Life Sciences, Inc. CENTRAL INDEX KEY: 0001645666 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473366145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-822-5600 MAIL ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-07-24 0 0001645666 Kezar Life Sciences, Inc. KZR 0001744253 Kirk Christopher J. C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 0 Stock Option (right to buy) 22.85 2023-07-24 4 D 0 87500 D 2029-01-05 Common Stock 87500 0 D Stock Option (right to buy) 2.28 2023-07-24 4 A 0 87500 A 2029-01-05 Common Stock 87500 87500 D Stock Option (right to buy) 3.29 2023-07-24 4 D 0 125000 D 2030-01-11 Common Stock 125000 0 D Stock Option (right to buy) 2.28 2023-07-24 4 A 0 125000 A 2030-01-11 Common Stock 125000 125000 D Stock Option (right to buy) 5.45 2023-07-24 4 D 0 260000 D 2031-01-07 Common Stock 260000 0 D Stock Option (right to buy) 2.28 2023-07-24 4 A 0 260000 A 2031-01-07 Common Stock 260000 260000 D Stock Option (right to buy) 14.55 2023-07-24 4 D 0 170000 D 2032-01-04 Common Stock 170000 0 D Stock Option (right to buy) 2.28 2023-07-24 4 A 0 170000 A 2032-01-04 Common Stock 170000 170000 D Stock Option (right to buy) 6.84 2023-07-24 4 D 0 190000 D 2033-01-07 Common Stock 190000 0 D Stock Option (right to buy) 2.28 2023-07-24 4 A 0 190000 A 2033-01-07 Common Stock 190000 190000 D Fully vested and exercisable. On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged. One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 1, 2020, subject to the Reporting Person continuing to provide service through each such date. One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 1, 2021, subject to the Reporting Person continuing to provide service through each such date. One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 5, 2022, subject to the Reporting Person continuing to provide service through each such date. One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 8, 2023, subject to the Reporting Person continuing to provide service through each such date. /s/ Marc Belsky, Attorney-in-Fact 2023-07-26